Cargando…

High Dose Steroids as First-Line Treatment Increased the Risk of In-Hospital Infections in Patients With Anti-NMDAR Encephalitis

OBJECTIVE: To address the effects of high dose steroids on in-hospital infection and neurologic outcome in anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis patients. METHODS: We retrospectively reviewed the clinical data of anti-NMDAR encephalitis patients in West China Hospital, the Thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jierui, Lin, Jingfang, Wang, Minjin, Meng, Zirui, Zhou, Dong, Li, Jinmei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718407/
https://www.ncbi.nlm.nih.gov/pubmed/34975861
http://dx.doi.org/10.3389/fimmu.2021.774664
_version_ 1784624718038433792
author Wang, Jierui
Lin, Jingfang
Wang, Minjin
Meng, Zirui
Zhou, Dong
Li, Jinmei
author_facet Wang, Jierui
Lin, Jingfang
Wang, Minjin
Meng, Zirui
Zhou, Dong
Li, Jinmei
author_sort Wang, Jierui
collection PubMed
description OBJECTIVE: To address the effects of high dose steroids on in-hospital infection and neurologic outcome in anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis patients. METHODS: We retrospectively reviewed the clinical data of anti-NMDAR encephalitis patients in West China Hospital, the Third Hospital of Mianyang and Mianyang Central Hospital between October 2011 and August 2020. The development of infections, inflammatory factors, neurologic outcome at discharge and risk factors for in-hospital infection were assessed in patients with and without high dose steroid therapy before and after immunotherapy. Least absolute shrinkage and selection operator (LASSO) regression and logistic regression models were established to assess risk factors for in-hospital infection. RESULTS: A total of 278 patients with anti-NMDAR encephalitis were included in the study. Thirty-four patients received high dose methylprednisolone (IVMP) therapy only, 84 patients received intravenous immunoglobulin (IVIG) therapy, and 160 patients received IVIG and IVMP therapy. Compared with the IVIG group, IVIG + IVMP group had a higher infection rate (64.38% vs 39.29%, P < 0.001), a higher incidence of noninfectious complications (76.25% vs 61.90%, P = 0.018) and a higher modified Rankin Scale (mRS) score at discharge from the hospital (3 vs 2, P < 0.001). Inflammatory indicators, including white blood cell (WBC) count, neutrophil-to-lymphocyte ratio (NLR) and systemic immune-inflammation index (SII), were higher (9.93 vs 5.65, 6.94 vs 3.47 and 1.47 vs 0.70, respectively, P < 0.001) in the IVIG + IVMP group than in the IVIG group. Moreover, lymphocyte-to-monocyte ratio (LMR) was lower (2.20 vs 2.54, P = 0.047) in the IVIG + IVMP group. The LASSO model showed that mRS score on admission, seizure, body temperature, uric acid (URIC), cerebrospinal fluid immunoglobulin G (CSF IgG), NLR and LMR were risk factors for in-hospital infection. The prediction model exhibited an area under the curve (AUC) of 0.885. CONCLUSIONS: High dose steroids therapy was significantly associated with higher in-hospital infectious complication rates and a poor short-term prognosis in relatively severe anti-NMDAR encephalitis patients. The established prediction model might be helpful to reduce the risk of in-hospital infection.
format Online
Article
Text
id pubmed-8718407
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-87184072022-01-01 High Dose Steroids as First-Line Treatment Increased the Risk of In-Hospital Infections in Patients With Anti-NMDAR Encephalitis Wang, Jierui Lin, Jingfang Wang, Minjin Meng, Zirui Zhou, Dong Li, Jinmei Front Immunol Immunology OBJECTIVE: To address the effects of high dose steroids on in-hospital infection and neurologic outcome in anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis patients. METHODS: We retrospectively reviewed the clinical data of anti-NMDAR encephalitis patients in West China Hospital, the Third Hospital of Mianyang and Mianyang Central Hospital between October 2011 and August 2020. The development of infections, inflammatory factors, neurologic outcome at discharge and risk factors for in-hospital infection were assessed in patients with and without high dose steroid therapy before and after immunotherapy. Least absolute shrinkage and selection operator (LASSO) regression and logistic regression models were established to assess risk factors for in-hospital infection. RESULTS: A total of 278 patients with anti-NMDAR encephalitis were included in the study. Thirty-four patients received high dose methylprednisolone (IVMP) therapy only, 84 patients received intravenous immunoglobulin (IVIG) therapy, and 160 patients received IVIG and IVMP therapy. Compared with the IVIG group, IVIG + IVMP group had a higher infection rate (64.38% vs 39.29%, P < 0.001), a higher incidence of noninfectious complications (76.25% vs 61.90%, P = 0.018) and a higher modified Rankin Scale (mRS) score at discharge from the hospital (3 vs 2, P < 0.001). Inflammatory indicators, including white blood cell (WBC) count, neutrophil-to-lymphocyte ratio (NLR) and systemic immune-inflammation index (SII), were higher (9.93 vs 5.65, 6.94 vs 3.47 and 1.47 vs 0.70, respectively, P < 0.001) in the IVIG + IVMP group than in the IVIG group. Moreover, lymphocyte-to-monocyte ratio (LMR) was lower (2.20 vs 2.54, P = 0.047) in the IVIG + IVMP group. The LASSO model showed that mRS score on admission, seizure, body temperature, uric acid (URIC), cerebrospinal fluid immunoglobulin G (CSF IgG), NLR and LMR were risk factors for in-hospital infection. The prediction model exhibited an area under the curve (AUC) of 0.885. CONCLUSIONS: High dose steroids therapy was significantly associated with higher in-hospital infectious complication rates and a poor short-term prognosis in relatively severe anti-NMDAR encephalitis patients. The established prediction model might be helpful to reduce the risk of in-hospital infection. Frontiers Media S.A. 2021-12-17 /pmc/articles/PMC8718407/ /pubmed/34975861 http://dx.doi.org/10.3389/fimmu.2021.774664 Text en Copyright © 2021 Wang, Lin, Wang, Meng, Zhou and Li https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Wang, Jierui
Lin, Jingfang
Wang, Minjin
Meng, Zirui
Zhou, Dong
Li, Jinmei
High Dose Steroids as First-Line Treatment Increased the Risk of In-Hospital Infections in Patients With Anti-NMDAR Encephalitis
title High Dose Steroids as First-Line Treatment Increased the Risk of In-Hospital Infections in Patients With Anti-NMDAR Encephalitis
title_full High Dose Steroids as First-Line Treatment Increased the Risk of In-Hospital Infections in Patients With Anti-NMDAR Encephalitis
title_fullStr High Dose Steroids as First-Line Treatment Increased the Risk of In-Hospital Infections in Patients With Anti-NMDAR Encephalitis
title_full_unstemmed High Dose Steroids as First-Line Treatment Increased the Risk of In-Hospital Infections in Patients With Anti-NMDAR Encephalitis
title_short High Dose Steroids as First-Line Treatment Increased the Risk of In-Hospital Infections in Patients With Anti-NMDAR Encephalitis
title_sort high dose steroids as first-line treatment increased the risk of in-hospital infections in patients with anti-nmdar encephalitis
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718407/
https://www.ncbi.nlm.nih.gov/pubmed/34975861
http://dx.doi.org/10.3389/fimmu.2021.774664
work_keys_str_mv AT wangjierui highdosesteroidsasfirstlinetreatmentincreasedtheriskofinhospitalinfectionsinpatientswithantinmdarencephalitis
AT linjingfang highdosesteroidsasfirstlinetreatmentincreasedtheriskofinhospitalinfectionsinpatientswithantinmdarencephalitis
AT wangminjin highdosesteroidsasfirstlinetreatmentincreasedtheriskofinhospitalinfectionsinpatientswithantinmdarencephalitis
AT mengzirui highdosesteroidsasfirstlinetreatmentincreasedtheriskofinhospitalinfectionsinpatientswithantinmdarencephalitis
AT zhoudong highdosesteroidsasfirstlinetreatmentincreasedtheriskofinhospitalinfectionsinpatientswithantinmdarencephalitis
AT lijinmei highdosesteroidsasfirstlinetreatmentincreasedtheriskofinhospitalinfectionsinpatientswithantinmdarencephalitis